Clinical Trial Update: Clinical Characteristics and Mechanism Research of Inhibitors of Janus Kinase in the Idiopathic Inflammatory Myopathies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating Janus kinase inhibitors in idiopathic inflammatory myopathies, focusing on characteristics and mechanism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Inflammatory Myopathies

Snippet

Sponsor: Peking University People's Hospital | Conditions: Idiopathic Inflammatory Myopathies | Phase 2 | Status: UNKNOWN